Virpax licenses LipoCure’s Liposome drug delivery technology
The first investigational product, LBL100 (3% bupivacaine in Lipogel), is being developed as a long-acting local anesthetic for post-operative pain. Virpax expects to file a Pre-Investigational New Drug